Get 20% lifetime commission for referring investors to digrin.com
here.
Vanda Pharmaceuticals Inc. ( VNDA) - Key Metrics
VNDA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.84 | -$1.04 | -$1.35 | -$1.36 |
| 2026Q1 | $0.87 | -$0.82 | -$0.84 | -$0.85 |
| 2025Q4 | $0.97 | -$2.39 | -$0.50 | -$0.50 |
| 2025Q3 | $0.96 | -$0.38 | -$0.54 | -$0.54 |
| 2025Q2 | $0.89 | -$0.46 | -$0.26 | -$0.26 |
VNDA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.47 |
| 2026Q1 | 0% | -2.11 |
| 2025Q4 | 0% | -0.92 |
| 2025Q3 | 0% | -3.28 |
| 2025Q2 | 0% | -2.57 |
VNDA
Price: $5.23
52 week price:
Earnings Per Share: -4.70 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 456204
Ebitda: -1.4 millionMarket Capitalization: 303.5 million